Effect of weekly vitamin D supplementation on the severity of atopic dermatitis and type 2 immunity biomarkers in children: A randomized controlled trial.

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

However, randomized trials of VD supplementation in AD have had equivocal results, and there is little information regarding the effect of VD supplementation on type 2 immunity in AD patients.

Who Took Part

The abstract describes 2 patients taking part.

The age groups tagged for this paper are young children and children, both men and women.

How the Study Was Run

The researchers set it up as a randomized, double-blind and placebo-controlled study.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.

The comparison arm used a placebo, so changes seen with Vitamin D, K2, Magnesium and Zinc could be set against what happens without it.

The researchers performed a randomized, double-blind, placebo-controlled trial.

The primary outcome was the change in the Severity Scoring of AD (SCORAD).

What Was Measured

The subject headings attached to it are Dermatitis, Atopic, Biomarkers, Dietary Supplements, Cholecalciferol, Vitamin D, Vitamin D Deficiency and Immunoglobulin E.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 2 patients.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The abstract goes on to report its results in about 7 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2024 (Journal of the European Academy of Dermatology and Venereology : JEADV), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.